Get the Weekly Intelligence Brief — top committee picks every Sunday.

HP vs NOV

Helmerich & Payne, Inc. vs NOV Inc. — AI-powered side-by-side comparison
HP
Helmerich & Payne, Inc.
58
Watch
VS
NOV
NOV Inc.
71
Buy
MetricHPNOV
AI Score 58 71
Price $42.52 $21.02
P/E Ratio -30.40× 80.85×
ROE -6.1% 2.3%
Revenue Growth YoY
Gross Margin 15.0% 20.5%
Debt / Equity 0.72× 0.37×
Dividend Yield 2.3% 2.0%
RSI (14) 84.3 66.0
Beta 0.619 0.936
Expected Upside +0.7%

AI Committee View

Current Innellis committee reasoning for HP versus NOV.
NOV leads by 13 points.

NOV scores 71/100 (Buy) versus HP at 58/100 (Watch).

HP Committee View
50% agreement
6 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 30.1% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Price-to-book of 0.8x is a discount to asset value — Value
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • ROE of only -5.2% -- cheap may mean cheap for a reason — Value
  • RSI at 84 is in overbought territory — Technical
  • Price structure (LH_LL) contradicts the uptrend -- mixed signals — Technical
NOV Committee View
75% agreement
4 analysts

The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is news sentiment is negative (-0.20 across 27 articles, 14d). The committee is constructive but not yet at full conviction.

Bull Case
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • News sentiment is negative (-0.20 across 27 articles, 14d) — News
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
HP Full Analysis NOV Full Analysis